Capstone Investment Advisors, LLC Amgen Inc Transaction History

Capstone Investment Advisors, LLC

$29.5 Billion
Q2 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 3,525 shares of AMGN stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,525

Previous 7,647 53.9%

Holding current value

$1.12 Million

Previous $2.17 Million 49.36%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $1.08 Million - $1.32 Million	-4,122 Reduced 53.9%	3,525 $1.1 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $1.6 Million - $1.93 Million	5,953 Added 351.42%	7,647 $2.17 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $228,851 - $258,171	-895 Reduced 34.57%	1,694 $487,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $2.48 Million - $3.08 Million	-11,330 Reduced 81.4%	2,589 $695,000
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $1.74 Million - $2.06 Million	8,115 Added 139.82%	13,919 $3.09 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $1.31 Million - $1.6 Million	5,804 New	5,804 $1.4 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $731,964 - $825,522	-3,261 Reduced 98.55%	48 $11,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $324,608 - $361,233	1,407 Added 73.97%	3,309 $805,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $14.1 Million - $15.6 Million	-64,468 Reduced 97.13%	1,902 $460,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $14.5 Million - $16.6 Million	-73,142 Reduced 52.43%	66,370 $14.9 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $23.5 Million - $27.5 Million	110,695 Added 384.13%	139,512 $29.7 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $6.83 Million - $7.58 Million	-29,249 Reduced 50.37%	28,817 $7.02 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $7.38 Million - $8.79 Million	34,103 Added 142.32%	58,066 $13.4 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $3.59 Million - $4.62 Million	19,000 Added 382.83%	23,963 $5.78 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $5.64 Million - $6.76 Million	-32,389 Reduced 86.71%	4,963 $960,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $1.38 Million - $1.62 Million	8,270 Added 28.44%	37,352 $6.88 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $4.96 Million - $5.6 Million	27,447 Added 1678.72%	29,082 $5.53 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $197,101 - $221,387	1,187 Added 264.96%	1,635 $302,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $75,904 - $88,704	448 New	448 $76,000

Others Institutions Holding AMGN

# of Institutions

3,056

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Amgen Inc Transaction History